Human Papillomavirus (HPV) 15 Genotype Detection Kit (Fluorescence PCR Melting Curve Method) ̇

A diagnostic kit for qualitative detection of 15 high-risk HPV E6/E7 mRNA types (16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) in cervical exfoliated cell samples. The kit detects HPV at the viral gene transcription level, directly reflecting the expression of HR-HPV E6/E7 oncogenic genes, and is closely associated with viral integration and cellular malignant transformation. It can serve as a risk assessment tool for cervical cancer and precancerous lesions, providing accurate information for cervical cancer screening and disease prediction.

In vitro qualitative detection kit for 15 high-risk HPV E6/E7 mRNA subtypes in cervical exfoliated cell samples. Detects HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68 for cervical cancer and precancerous lesion risk assessment. NMPA Class III medical device registered.

Molecular assay for identifying 14 WHO-defined high-risk HPV types and 4 additional clinically relevant HPV types associated with cervical cancer. Enables comprehensive cervical cancer risk stratification.

HPV E7 protein detection kit using immunocytochemical methodology for cervical cytology screening. This in vitro diagnostic test identifies HPV E7 protein expression in cervical samples to support the detection of cervical lesions and dysplasia. The kit enables standardized pathology assessment with compatible automated analysis integration for improved diagnostic accuracy.

A quantitative diagnostic test kit for detecting human cytomegalovirus nucleic acid using fluorescence PCR technology. This kit enables both detection and quantification of CMV genetic material for clinical diagnostic purposes.

A molecular diagnostics reagent kit for human MTHFR gene typing using PCR with fluorescent probes. The kit enables genetic analysis for clinical and personalized medicine applications.

PCR-based detection kit for HCMV nucleic acids used in early diagnosis and assessment of fetal, neonatal, and maternal infections. Enables timely clinical management of HCMV-related complications.

A fully enclosed diagnostic kit with preloaded reagents for 6-plex detection of HPV types (HPV16, HPV18, and others) using cervical exfoliated cells and genital secretion samples. The kit employs magnetic beads extraction, purification, and qPCR method with results available within 2 hours and internal control monitoring throughout the process. It requires no freezer storage or transportation.

A diagnostic test kit detecting 18 types of human papillomavirus including 14 high-risk types recognized by WHO as causative agents of cervical cancer and 4 medium-risk types associated with cervical cancer, using hybrid capture-chemiluminescence method.

A PCR fluorescence probe method diagnostic kit for detecting 16 high-risk human papillomavirus types and genotyping HPV 16 and 18. The kit provides 6-plex detection with internal control and is designed for use with the Galaxy Nano system.

A qualitative test kit for detecting and genotyping 15 types of human papillomavirus (HPV) DNA in cervical exfoliative cells or urine samples using fluorescent PCR methodology. The kit can identify and differentiate HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, and 73.

A fluorescence PCR-based qualitative detection kit for identifying 15 types of human papillomavirus DNA from cervical or urine samples. Includes CE certification and enables specific genotype differentiation.